SEC Company Response from CLOVER HEALTH INVESTMENTS, (CLOV) — May 18, 2022
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) (CIK 0001801170)
Date: May 18, 2022 · CIK: 0001801170 · Accession: 0001801170-22-000029
AI Filing Summary & Sentiment
File numbers found in text: 333-264801
Letter
Document
Clover Health Investments, Corp.
3401 Mallory Lane, Suite 210
Franklin, Tennessee 37067
May 18, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Clover Health Investments, Corp.
Registration Statement on Form S-3
Filed May 9, 2022
File No. 333-264801
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Clover Health Investments, Corp. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 be accelerated so that the Registration Statement may become effective at 4:00 p.m., Eastern Time, on May 20, 2022, or as soon thereafter as practicable.
If you have any questions regarding this request, please contact Andrew B. Barkan or Brian Hecht of Fried, Frank, Harris, Shriver & Jacobson LLP, counsel to the Company, at (212) 859-8468 or (212) 859-8926, respectively.
Very truly yours,
CLOVER HEALTH INVESTMENTS, CORP.
Show Raw Text
CORRESP 1 filename1.htm Document Clover Health Investments, Corp. 3401 Mallory Lane, Suite 210 Franklin, Tennessee 37067 May 18, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Clover Health Investments, Corp. Registration Statement on Form S-3 Filed May 9, 2022 File No. 333-264801 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Clover Health Investments, Corp. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 be accelerated so that the Registration Statement may become effective at 4:00 p.m., Eastern Time, on May 20, 2022, or as soon thereafter as practicable. If you have any questions regarding this request, please contact Andrew B. Barkan or Brian Hecht of Fried, Frank, Harris, Shriver & Jacobson LLP, counsel to the Company, at (212) 859-8468 or (212) 859-8926, respectively. Very truly yours, CLOVER HEALTH INVESTMENTS, CORP. By: /s/ Vivek Garipalli Name: Vivek Garipalli Title: Chief Executive Officer